School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang 261053, China.
School of Medical Science & Menzies Health Institute Queensland, Griffith University, Gold Coast, Qld 4215, Australia.
Biomed Res Int. 2020 May 16;2020:8349712. doi: 10.1155/2020/8349712. eCollection 2020.
LL-37, also called cathelicidin, is an important part of the human immune system, which can resist various pathogens. A plethora of experiments have demonstrated that it has the multifunctional effects of immune regulation, in addition to antimicrobial activity. Recently, there have been increasing interest in its immune function. It was found that LL-37 can have two distinct functions in different tissues and different microenvironments. Thus, it is necessary to investigate LL-37 immune functions from the two sides of the same coin. On the one side, LL-37 promotes inflammation and immune response and exerts its anti-infective and antitumor effects; on the other side, it has the ability to inhibit inflammation and promote carcinogenesis. This review presents a brief summary of its expression, structure, and immunomodulatory effects as well as brief discussions on the role of this small peptide as a key factor in the development and treatment of various inflammation-related diseases and cancers.
LL-37,也称为抗菌肽,是人体免疫系统的重要组成部分,能够抵抗各种病原体。大量实验表明,它除了具有抗菌活性外,还具有免疫调节的多功能作用。最近,人们对其免疫功能的兴趣日益增加。研究发现,LL-37 在不同组织和不同微环境中具有两种截然不同的功能。因此,有必要从同一枚硬币的两面来研究 LL-37 的免疫功能。一方面,LL-37 促进炎症和免疫反应,发挥其抗感染和抗肿瘤作用;另一方面,它具有抑制炎症和促进肿瘤发生的能力。本文简要概述了其表达、结构和免疫调节作用,并简要讨论了这种小肽作为各种与炎症相关的疾病和癌症发展和治疗的关键因素的作用。